Published on 31 Jan 2025 on Investing.com
Abbott Laboratories (NYSE:ABT) Posts Q4 Sales In Line With Estimates By Stock...
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue...
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free